Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
D. Bottero, E. Rudi, P. M. Aispuro…·D. Hozbor
This study evaluates the effectiveness of heterologous booster vaccines against Omicron BA.1 using a mouse model, showing that mRNA-based vaccines outperform vector-based ones, while heterologous boosters improve immune responses.
D. J. Perera, P. Domenech, G. G. Babuadze…·M. Ndao
BCG enhances anti-SARS-CoV-2 immunity and protection afforded by a novel adenovirus-vectored vaccine.
F. C. Stark, B. Akache, L. Deschatelets…·J. Zimmermann
This study evaluates an intranasal vaccine formulation containing a proteosome-adjuvanted SARS-CoV-2 Spike protein, showing immunogenicity and efficacy in mice and hamsters against multiple variants.
M. A. Rossotti, H. van Faassen, A. Tran…·J. Tanha
This paper presents a diverse set of nanobodies targeting SARS-CoV-2 spike glycoprotein with broad neutralization activity against multiple variants and high in vivo efficacy.
M. Stuible, C. Gervais, S. Lord-Dufour…·Y. Durocher
The paper develops a method to rapidly produce high-yield, full-length SARS-CoV-2 spike protein using CHO cells and reports yields of 100-150 mg/L.